AEMD : Summary for Aethlon Medical, Inc. - Yahoo Finance

U.S. Markets closed

Aethlon Medical, Inc. (AEMD)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.61+0.03 (+0.66%)
At close: 4:00 PM EST
People also watch:
CTSOAMARADXSBKYIIBIO
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close4.58
Open4.58
Bid4.35 x 100
Ask5.29 x 300
Day's Range4.54 - 4.69
52 Week Range4.02 - 9.09
Volume96,041
Avg. Volume23,419
Market Cap35.61M
Beta2.69
PE Ratio (TTM)-5.15
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube17 days ago

    ETFs with exposure to Aethlon Medical, Inc. : November 16, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Aethlon Medical, Inc. Here are 5 ETFs with the largest exposure to AEMD-US. Comparing the performance and risk of Aethlon Medical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Aethlon Medical, Inc. :AEMD-US: Earnings Analysis: Q2, 2017 By the Numbers : November 14, 2016
    Capital Cube19 days ago

    Aethlon Medical, Inc. :AEMD-US: Earnings Analysis: Q2, 2017 By the Numbers : November 14, 2016

    Categories: Yahoo Finance Get free summary analysis Aethlon Medical, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Aethlon Medical, Inc. – Inovio Pharmaceuticals, Inc., Idera Pharmaceuticals, Inc., Coherent, Inc., Bruker Corporation, PerkinElmer, Inc., pSivida Corp., Pacific Biosciences of California, Inc., Accelerate Diagnostics, Inc. and Sparton ... Read more (Read more...)

  • PR Newswire23 days ago

    Aethlon Medical Announces Fiscal 2017 Second Quarter Results

    SAN DIEGO, Nov. 10, 2016 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a developer of immunotherapeutic technologies to combat infectious disease and cancer, today announced results for its fiscal ...